Diet and prescription drugs appear to slow biological aging; supplements do not
Biological age can be measured through chemical patterns on DNA. But which treatments actually turn that clock back? Yale researchers examined 51 studies to find out.
Biological aging is increasingly measured using epigenetic clocks: tools that analyse chemical tags called methyl groups on DNA to estimate how old someone is biologically. This can differ from chronological age. Researchers at the Yale School of Medicine analysed 51 clinical studies and more than 110 of these DNA-based markers. They grouped interventions into four categories: prescription drugs, lifestyle changes, over-the-counter supplements, and medical procedures. The study was published in Nature Medicine.
What works and what does not
The researchers found that combinations of physical exercise and healthy eating, including Mediterranean, low-fat, and low-carbohydrate diets, consistently reduced biological age markers. The strongest reductions were seen with certain prescription drugs: metformin, semaglutide, and anti-inflammatory drugs also used for other conditions. Over-the-counter supplements included in the analysed studies appear largely ineffective and did not produce measurable reductions in biological age.
The researchers emphasise that a lower biological age score does not automatically mean someone will live longer or develop fewer diseases. The precise meaning of that change is not yet fully understood. It is also not established whether the reductions are directly caused by the treatment or influenced by other factors.
Faster testing of aging treatments
A further potential benefit of validated biological age markers is that they could speed up the evaluation of anti-aging treatments. Rather than waiting decades for data from large-scale trials, it might eventually be possible to assess whether a treatment works within years or months. This remains an expectation, not an established fact.
Search terms to explore further: biological age measurement aging intervention, biological aging markers, metformin age-related aging